Literature DB >> 35971373

Intractable Nausea in a Heart Transplant Patient.

Julian Yet Kwong Horman1, Michael Schultz1.   

Abstract

We present a case of a 59-year-old woman who had been recently diagnosed with a cavitary lung nodule and then started on voriconazole; she had been diagnosed with breast cancer about 10 years prior, which had been treated with anthracyclines and subsequent non-ischemic cardiomyopathy, ultimately requiring an orthotopic heart transplant. She presented to the hospital due to nausea and abdominal pain. She was found to have cholelithiasis, without cholecystitis, and was initially discharged with plans for an outpatient cholecystectomy. However, nausea and pain persisted, and hence she was readmitted and had a cholecystectomy but her nausea continued. Further workup revealed an elevated voriconazole level, and her nausea resolved once the voriconazole was discontinued.
Copyright © 2022, Yet Kwong Horman et al.

Entities:  

Keywords:  heart transplant; immunosuppression; nausea and vomiting; orthotopic heart transplant; voriconazole toxicity

Year:  2022        PMID: 35971373      PMCID: PMC9373880          DOI: 10.7759/cureus.26804

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.

Authors:  Maria Rosa Costanzo; Anne Dipchand; Randall Starling; Allen Anderson; Michael Chan; Shashank Desai; Savitri Fedson; Patrick Fisher; Gonzalo Gonzales-Stawinski; Luigi Martinelli; David McGiffin; Jon Smith; David Taylor; Bruno Meiser; Steven Webber; David Baran; Michael Carboni; Thomas Dengler; David Feldman; Maria Frigerio; Abdallah Kfoury; Daniel Kim; Jon Kobashigawa; Michael Shullo; Josef Stehlik; Jeffrey Teuteberg; Patricia Uber; Andreas Zuckermann; Sharon Hunt; Michael Burch; Geetha Bhat; Charles Canter; Richard Chinnock; Marisa Crespo-Leiro; Reynolds Delgado; Fabienne Dobbels; Kathleen Grady; W Kao; Jaqueline Lamour; Gareth Parry; Jignesh Patel; Daniela Pini; Jeffrey Towbin; Gene Wolfel; Diego Delgado; Howard Eisen; Lee Goldberg; Jeff Hosenpud; Maryl Johnson; Anne Keogh; Clive Lewis; John O'Connell; Joseph Rogers; Heather Ross; Stuart Russell; Johan Vanhaecke
Journal:  J Heart Lung Transplant       Date:  2010-08       Impact factor: 10.247

2.  Voriconazole: the newest triazole antifungal agent.

Authors:  Nickie D Greer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-04

3.  The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town.

Authors:  C N Barnard
Journal:  S Afr Med J       Date:  1967-12-30

4.  Risk factors for invasive fungal disease in heart transplant recipients.

Authors:  Alexander S Rabin; Michael M Givertz; Gregory S Couper; Margaret M Shea; Driele Peixoto; Deborah S Yokoe; Lindsey R Baden; Francisco M Marty; Sophia Koo
Journal:  J Heart Lung Transplant       Date:  2014-10-02       Impact factor: 10.247

5.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match.

Authors:  Kiran K Khush; Wida S Cherikh; Daniel C Chambers; Michael O Harhay; Don Hayes; Eileen Hsich; Bruno Meiser; Luciano Potena; Amanda Robinson; Joseph W Rossano; Aparna Sadavarte; Tajinder P Singh; Andreas Zuckermann; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

6.  Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High-Complexity Hospital.

Authors:  Maria Clara Padovani de Souza; Andrezza Gouvêa Dos Santos; Adriano Max Moreira Reis
Journal:  J Clin Pharmacol       Date:  2016-06-14       Impact factor: 3.126

7.  Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.

Authors:  Céline Eiden; Hélène Peyrière; Marylène Cociglio; Samira Djezzar; Sylvie Hansel; Jean-Pierre Blayac; Dominique Hillaire-Buys
Journal:  Ann Pharmacother       Date:  2007-04-24       Impact factor: 3.154

Review 8.  Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.

Authors:  H Ruth Ashbee; Rosemary A Barnes; Elizabeth M Johnson; Malcolm D Richardson; Rebecca Gorton; William W Hope
Journal:  J Antimicrob Chemother       Date:  2013-12-29       Impact factor: 5.790

Review 9.  Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.

Authors:  Haiying Jin; Tiansheng Wang; Bonnie A Falcione; Keith M Olsen; Ken Chen; Huilin Tang; John Hui; Suodi Zhai
Journal:  J Antimicrob Chemother       Date:  2016-03-10       Impact factor: 5.790

10.  Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.

Authors:  Stéphanie Pons; Romain Sonneville; Lila Bouadma; Lenka Styfalova; Stéphane Ruckly; Mathilde Neuville; Aguila Radjou; Jordane Lebut; Marie-Pierre Dilly; Bruno Mourvillier; Richard Dorent; Patrick Nataf; Michel Wolff; Jean-François Timsit
Journal:  Ann Intensive Care       Date:  2019-01-25       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.